🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and effectiveness of a combination of s...
Status
Recruiting
Location
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
Start Date
2023-07-01
Trial ID
NCT05915442
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation, and dose-expansion, with a ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-11-06
Trial ID
NCT04104672
Treatments Being Tested
This phase Ib/II trial tests the safety, side effects, and best dose of que...
Status
Not Yet Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-12-01
Trial ID
NCT07667335
A Double-Blind, Randomized, Placebo-Controlled, Single Ascending Dose Study...
Status
Completed
Location
Nucleus Network
Start Date
2020-10-20
Trial ID
NCT04575311
This is a double-blind, randomized, placebo-controlled, single- and multipl...
Status
Completed
Location
Melbourne, VIC
Start Date
2018-10-16
Trial ID
NCT03677973
This phase I/II study tests how well zimberelimab and quemliclustat work in...
Status
Recruiting
Location
Yonemoto,Lisa
Start Date
2023-03-07
Trial ID
NCT05688215
This randomized phase 1b/2 open-label study will evaluate the antitumour ac...
Status
Completed
Location
Arizona Clinical Research Center Inc
Start Date
2021-05-10
Trial ID
NCT04660812
Treatments Being Tested
This is a Phase 1b/2, open-label, multicenter platform trial to evaluate th...
Status
Completed
Location
The Oncology Institute of Hope & Innovation
Start Date
2020-07-07
Trial ID
NCT04381832
Treatments Being Tested
The purpose of this study is to combine standard radiation therapy with dru...
Status
Recruiting
Location
Northwell Health R.J. Zuckerberg Cancer Center
Start Date
2024-05-10
Trial ID
NCT06048484
The purpose of the study is to investigate the routes of elimination and ov...
Status
Completed
Location
Research Site
Start Date
2026-02-03
Trial ID
NCT07364214
Treatments Being Tested